{"id":1000714,"date":"2026-09-04T09:54:36","date_gmt":"2026-09-04T13:54:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/"},"modified":"2026-09-04T09:54:36","modified_gmt":"2026-09-04T13:54:36","slug":"eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/","title":{"rendered":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm"},"content":{"rendered":"
\n

RADNOR, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com<\/a>), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT)<\/a> on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses.<\/p>\n

\n
\n EyePoint Reports Disappointing Phase 3 Clinical Trials <\/u>
\n <\/strong>
\n
On August 17, 2026, EyePoint issued a press release \u201cannounc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYU\u2122 (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD).\u201d Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint — change in best-corrected visual acuity versus on-label aflibercept — in the full dataset of the company\u2019s Phase 3 LUGANO trial in wet age-related macular degeneration.<\/p>\n

\n
\n EyePoint\u2019s Stock Drops Over 66%<\/u>
\n <\/strong>
\n
Following the news of EyePoint, Inc.\u2019s poor clinical trial results, the company\u2019s stock price fell over 66%.<\/p>\n

Investors who purchased EyePoint, Inc. (NASDAQ: EYPT) securities and experienced losses may have legal rights under the federal securities laws.<\/p>\n

\n
\n CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: <\/u>
\n <\/strong>
\n
If you purchased or acquired EyePoint, Inc. securities and have lost money on your investment, please provide your information here: https:\/\/www.ktmc.com\/eypt-eyepoint-inc-investigation?utm_campaign=hc?utm_source=Globe&utm_medium=pressrelease&utm_campaign=eypt&mktm=PR<\/a><\/p>\n

There is no cost or obligation to speak with an attorney.<\/p>\n

\n
\n ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC): <\/u>
\n <\/strong>\n <\/p>\n

Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm<\/a> in Securities and Class Actions, Legal 500\u2019s Tier 1 Rankings for Securities and M&A Litigation<\/a>, The National Law Journal\u2019s Plaintiff\u2019s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group\u2019s Honor Roll of Most Feared Law Firms, The Legal Intelligencer\u2019s Class Action Firm of the Year<\/a>, Lawdragon\u2019s Leading Plaintiff Financial Lawyers, and Law360\u2019s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.<\/p>\n

CONTACT:
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com<\/u><\/a><\/p>\n

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

RADNOR, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses. EyePoint Reports Disappointing Phase 3 Clinical Trials On August 17, 2026, EyePoint issued a press release \u201cannounc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYU\u2122 (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD).\u201d Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint — change in best-corrected visual acuity versus on-label aflibercept — in the full … <\/p>\n

Continue reading “EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000714","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses. EyePoint Reports Disappointing Phase 3 Clinical Trials On August 17, 2026, EyePoint issued a press release \u201cannounc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYU\u2122 (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD).\u201d Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint — change in best-corrected visual acuity versus on-label aflibercept — in the full … Continue reading "EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-04T13:54:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm\",\"datePublished\":\"2026-09-04T13:54:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/\"},\"wordCount\":449,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/\",\"name\":\"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=\",\"datePublished\":\"2026-09-04T13:54:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk","og_description":"RADNOR, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) — Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses. EyePoint Reports Disappointing Phase 3 Clinical Trials On August 17, 2026, EyePoint issued a press release \u201cannounc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYU\u2122 (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD).\u201d Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint — change in best-corrected visual acuity versus on-label aflibercept — in the full … Continue reading \"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-04T13:54:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm","datePublished":"2026-09-04T13:54:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/"},"wordCount":449,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/","name":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=","datePublished":"2026-09-04T13:54:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY0MyM3ODE4NjcxIzIwMTkzMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-inc-nasdaq-eypt-alert-investors-encouraged-to-contact-ktmc-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000714"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000714\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}